Literature DB >> 12695664

E2F and Ras synergize in transcriptionally activating p14ARF expression.

Eli Berkovich1, Yocheved Lamed, Doron Ginsberg.   

Abstract

The INK4a/ARF locus, which is frequently inactivated in human tumors, encodes two distinct tumor suppressive proteins, ARF and p16INK4a. ARF stabilizes and activates p53 by negating the effects of mdm2 on p53. Furthermore, its function is not restricted to the p53 pathway and it also inhibits cell proliferation in cells lacking p53. Expression of ARF is up-regulated in response to a number of oncogenic stimuli including E2F1. We show here that while oncogenic Ras does not significantly affect p1(4AR)F expression in normal human cells it activates p1(4AR)F in cells containing deregulated E2F. Moreover, oncogenic Ras and E2F1 synergize in activating p1(4AR)F expression. Activation of p1(4AR)F promoter by E2F1 persists in the absence of the consensus E2F-binding sites in this promoter, indicating that this activation also occurs through non- canonical binding sites. The activation by oncogenic Ras requires both E2F and Sp-1 activity, demonstrating the complex regulation of p14(ARF) in response to oncogenic stimuli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695664     DOI: 10.4161/cc.2.2.293

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

1.  EAPP, a novel E2F binding protein that modulates E2F-dependent transcription.

Authors:  Michael Novy; Regina Pohn; Peter Andorfer; Tina Novy-Weiland; Barbara Galos; Ludwig Schwarzmayr; Hans Rotheneder
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

2.  ETV1 positively regulates transcription of tumor suppressor ARF.

Authors:  Evan Zynda; Mark W Jackson; Partho Bhattacharya; Eugene S Kandel
Journal:  Cancer Biol Ther       Date:  2013-10-23       Impact factor: 4.742

3.  Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1.

Authors:  Yoon-Jae Song; Mark F Stinski
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis.

Authors:  K Evangelou; J Bartkova; A Kotsinas; I S Pateras; M Liontos; G Velimezi; M Kosar; T Liloglou; I P Trougakos; L Dyrskjot; C L Andersen; M Papaioannou; Y Drosos; G Papafotiou; Z Hodny; B Sosa-Pineda; X-R Wu; A Klinakis; T Ørntoft; J Lukas; J Bartek; V G Gorgoulis
Journal:  Cell Death Differ       Date:  2013-07-12       Impact factor: 15.828

5.  Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.

Authors:  Cho-Rok Jung; Jung Hwa Lim; Yoonjung Choi; Dae-Ghon Kim; Koo Jeong Kang; Seung-Moo Noh; Dong-Soo Im
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

6.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

7.  Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.

Authors:  Xingwu Wang; Meng Zha; Xiaocheng Zhao; Peng Jiang; Wenjing Du; Andrew Y H Tam; Yide Mei; Mian Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 8.  The roles and regulation of TBX3 in development and disease.

Authors:  Saif F Khan; Victoria Damerell; Rehana Omar; Michelle Du Toit; Mohsin Khan; Hapiloe Mabaruti Maranyane; Mihlali Mlaza; Jenna Bleloch; Claire Bellis; Bianca D B Sahm; Jade Peres; K N ArulJothi; Sharon Prince
Journal:  Gene       Date:  2019-10-26       Impact factor: 3.688

9.  ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information.

Authors:  Alexander Lachmann; Federico M Giorgi; Gonzalo Lopez; Andrea Califano
Journal:  Bioinformatics       Date:  2016-04-23       Impact factor: 6.937

Review 10.  Novel Biological Approaches for Testing the Contributions of Single DSBs and DSB Clusters to the Biological Effects of High LET Radiation.

Authors:  Veronika Mladenova; Emil Mladenov; George Iliakis
Journal:  Front Oncol       Date:  2016-06-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.